The
price of Sovaldi and its impact on the U.S. health care system
United States
Congress.
Senate.
Committee on Finance,
issuing body.
text
bibliography
Legislative materials.
dcu
2015
monographic
eng
2 volumes (viii, 1980 pages) : illustrations ; 24 cm.
prepared by the staffs of ranking member Ron Wyden and committee member Charles E. Grassley, Committee on Finance, United States Senate.
At head of title: 114th Congress, 1st session. Committee print.
Shipping list no.: 2016-0082-M.
"December 2015."
CRDP Project record.
Includes bibliographical references.
Microfiche. [Washington, D.C.] : U.S. Government Printing Office, [2016] 34 microfiches : negative.
n-us---
Sofosbuvir
Prices
United States
Hepatitis C
Chemotherapy
United States
Costs
Sulfonamides
Prices
United States
Antiviral agents
Prices
United States
Gilead Sciences (Firm)
KF31 .F5 2015
Y 4.F 49:S.PRT.114-20/
Y 4.F 49:S.PRT.114-20/
Price of Sovaldi and its impact on the U.S. health care system
(OCoLC)932019028
Price of Sovaldi and its impact on the U.S. health care system
(OCoLC)932136752
S. prt. ; 114-20
GPO
160419
20160809093803.0
ocn946944315
eng